A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Determining the Role of Vitronectin in Bacterial Resistance to Bactericidal Activity of Human Serum

684 views

July 8th, 2025

In This Article

Abstract

Source: Singh, B. et al., Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance. J. Vis. Exp. (2018)

This video demonstrates the role of vitronectin, a human serum glycoprotein, on bacterial resistance. Antibodies in the serum interact with bacterial surface proteins, activating complement proteins and forming the membrane attack complex, causing bacterial cell lysis. Vitronectin binding on bacterial membrane protein prevents the membrane attack complex formation, resulting in bacterial survival.

Protocol

All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines.

1. Analysis of Vn-dependent Resistance to the Bactericidal Activity of Human Serum

  1. Purchase normal human serum (NHS) from a commercial source. Prepare vitronectin or Vn-depleted serum (VDS). Replenish the VDS with 180 nM Vn which is equivalent to Vn present in NHS.
  2. Prepare heat-inactivated serum (HIS) by heating NHS at 56 °C for 30 minutes in order to inactivate complement proteins.    
    NOTE: The optimal serum concentration (5%) and incubation time (15 min) for the assay were determined empirically for Haemophilus influenzae type f (Hif); these parameters could vary for other bacterial pathogens.
  3. Culture bacteria (in this case, Hif M10 and the mutant Hif M10Δlph) to mid-log phase (OD600 = 0.3). Pellet bacteria by centrifugation at 3,500 x g for 10 min.
  4. Resuspend the bacterial pellet with 1 volume of dextrose gelatin Veronal buffer (DGVB++; pH 7.3) containing 2.5% (w/v) glucose, 2 mM magnesium chloride, MgCl2, 0.15 mM calcium chloride, CaCl2, and 0.1% (wt/vol) gelatin.
  5. Add 1.5 x 103 colony forming unit (CFU) of bacteria to 100 µL of DGVB++ containing 5% serum (NHS, HIS, VDS, or VDS+180 nM Vn). Incubate the sample at 37 °C for 15 min with shaking at 300 rpm.
  6. Remove a 10 µL aliquot from the reaction mixture at 0 min (T0 sample) and 15 min (Tt sample) and plate on chocolate agar. Incubate the plate at 37 °C overnight.
  7. After incubation, count the colonies appearing on the plate. Calculate the percentage of bacteria killed using the following equation: (colony forming unit or CFU at Tt)/(CFU at T0) × 100.

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
6 mL polystyrene round-bottom tube VWR89000-47812 × 75 mm style with cap
Normal human serum (NHS)Complement Technology, Inc.NHSPooled human serum
Calcium chloride (CaCl2)Sigma-AldrichC5670-500G
GlucoseSigma-AldrichG8270-1KG
GelatinSigma-AldrichG9391Suitable for cell culture
HemocytometerMarienfeld640210
Magnesium chloride (MgCl2)Sigma-AldrichM8266-1KG
Vitronectin (Vn) from human plasmaSigma-AldrichV8379-50UGCell culture grade
Shaker Stuart ScientificSTR6Platform shaker

Tags

Membrane Attack ComplexComplement ActivationSerum Bactericidal ActivityBacterial SurvivalCFU AssayChocolate Agar IncubationDGVB++ Buffer